Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination - PubMed (original) (raw)
Review
. 2012 Jan 26;23(2):145-52.
doi: 10.1515/revneuro-2011-068.
Affiliations
- PMID: 22499673
- DOI: 10.1515/revneuro-2011-068
Free article
Review
Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination
Eileah Loda et al. Rev Neurosci. 2012.
Free article
Abstract
Oligodendrocyte injury and inflammatory demyelination are key pathological abnormalities of multiple sclerosis (MS), and its animal model, i.e., the experimental autoimmune encephalomyelitis (EAE). Traditionally, they are viewed as destructive processes secondary to a dysregulated autoimmune reaction. New evidence emerged over the last decade indicating that oligodendrocytes are not merely immune targets but rather active participants in the neuroimmune network and, in fact, can regulate the events leading to inflammatory demyelination. In this review, we are discussing the role of interferon regulatory factor 1 (IRF-1) as a master transcription factor orchestrating oligodendrocyte injury and inflammatory demyelination in MS and EAE. We are also discussing the significance of IRF-1 signaling in the induction of oligodendrocyte pyroptosis, a Caspase 1-dependent pro-inflammatory cell death, as a disease-enhancing mechanism. Finally, we are drawing attention to IRF-1 as a potential therapeutic target in MS and to the importance of investigating other oligodendrocyte-dependent disease mechanisms.
Similar articles
- Overexpression of the dominant-negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitis.
Ren Z, Wang Y, Tao D, Liebenson D, Liggett T, Goswami R, Clarke R, Stefoski D, Balabanov R. Ren Z, et al. J Neurosci. 2011 Jun 8;31(23):8329-41. doi: 10.1523/JNEUROSCI.1028-11.2011. J Neurosci. 2011. PMID: 21653838 Free PMC article. - Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival.
Tegla CA, Cudrici C, Rus V, Ito T, Vlaicu S, Singh A, Rus H. Tegla CA, et al. J Neuroimmunol. 2009 Aug 18;213(1-2):3-11. doi: 10.1016/j.jneuroim.2009.06.006. Epub 2009 Jul 4. J Neuroimmunol. 2009. PMID: 19577811 Free PMC article. Review. - Activating transcription factor 6α deficiency exacerbates oligodendrocyte death and myelin damage in immune-mediated demyelinating diseases.
Stone S, Wu S, Jamison S, Durose W, Pallais JP, Lin W. Stone S, et al. Glia. 2018 Jul;66(7):1331-1345. doi: 10.1002/glia.23307. Epub 2018 Feb 13. Glia. 2018. PMID: 29436030 Free PMC article. - Interferon-gamma-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis.
Balabanov R, Strand K, Goswami R, McMahon E, Begolka W, Miller SD, Popko B. Balabanov R, et al. J Neurosci. 2007 Feb 21;27(8):2013-24. doi: 10.1523/JNEUROSCI.4689-06.2007. J Neurosci. 2007. PMID: 17314297 Free PMC article. - Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis.
Patel J, Balabanov R. Patel J, et al. Int J Mol Sci. 2012;13(8):10647-10659. doi: 10.3390/ijms130810647. Epub 2012 Aug 23. Int J Mol Sci. 2012. PMID: 22949885 Free PMC article. Review.
Cited by
- Transcriptomic Analysis of Fumarate Compounds Identifies Unique Effects of Isosorbide Di-(Methyl Fumarate) on NRF2, NF-kappaB and IRF1 Pathway Genes.
Swindell WR, Bojanowski K, Chaudhuri RK. Swindell WR, et al. Pharmaceuticals (Basel). 2022 Apr 11;15(4):461. doi: 10.3390/ph15040461. Pharmaceuticals (Basel). 2022. PMID: 35455458 Free PMC article. - Single-cell analysis reveals region-heterogeneous responses in rhesus monkey spinal cord with complete injury.
Fan Y, Wu X, Han S, Zhang Q, Sun Z, Chen B, Xue X, Zhang H, Chen Z, Yin M, Xiao Z, Zhao Y, Dai J. Fan Y, et al. Nat Commun. 2023 Aug 9;14(1):4796. doi: 10.1038/s41467-023-40513-5. Nat Commun. 2023. PMID: 37558705 Free PMC article. - RNA sequencing reveals distinct mechanisms underlying BET inhibitor JQ1-mediated modulation of the LPS-induced activation of BV-2 microglial cells.
Jung KH, Das A, Chai JC, Kim SH, Morya N, Park KS, Lee YS, Chai YG. Jung KH, et al. J Neuroinflammation. 2015 Feb 24;12:36. doi: 10.1186/s12974-015-0260-5. J Neuroinflammation. 2015. PMID: 25890327 Free PMC article. - Heparanome-Mediated Rescue of Oligodendrocyte Progenitor Quiescence following Inflammatory Demyelination.
Saraswat D, Welliver RR, Ravichandar R, Tripathi A, Polanco JJ, Broome J, Hurley E, Dutta R, Feltri ML, Sim FJ. Saraswat D, et al. J Neurosci. 2021 Mar 10;41(10):2245-2263. doi: 10.1523/JNEUROSCI.0580-20.2021. Epub 2021 Jan 20. J Neurosci. 2021. PMID: 33472827 Free PMC article. - IFN Regulatory Factor 1 Mediates Macrophage Pyroptosis Induced by Oxidized Low-Density Lipoprotein in Patients with Acute Coronary Syndrome.
Guo M, Yan R, Yao H, Duan L, Sun M, Xue Z, Jia Y. Guo M, et al. Mediators Inflamm. 2019 Dec 1;2019:2917128. doi: 10.1155/2019/2917128. eCollection 2019. Mediators Inflamm. 2019. PMID: 31871426 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources